Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Experimental Autoimmune Encephalomyelitis Potentiates Mouse Mast Cell Protease 4-Dependent Pressor Responses to Centrally or Systemically Administered Big Endothelin-1.

Desbiens L, Lapointe C, Gendron L, Gharagozloo M, Vincent L, Pejler G, Gris D, D'Orléans-Juste P.

J Pharmacol Exp Ther. 2019 Sep;370(3):437-446. doi: 10.1124/jpet.118.256016. Epub 2019 Jun 27.

PMID:
31248979
2.

NLRX1 Enhances Glutamate Uptake and Inhibits Glutamate Release by Astrocytes.

Mahmoud S, Gharagozloo M, Simard C, Amrani A, Gris D.

Cells. 2019 Apr 30;8(5). pii: E400. doi: 10.3390/cells8050400.

3.

Astrocytes Maintain Glutamate Homeostasis in the CNS by Controlling the Balance between Glutamate Uptake and Release.

Mahmoud S, Gharagozloo M, Simard C, Gris D.

Cells. 2019 Feb 20;8(2). pii: E184. doi: 10.3390/cells8020184. Review.

4.

Exploring the role of physical activity and exercise for managing vascular comorbidities in people with multiple sclerosis: A scoping review.

Ewanchuk BW, Gharagozloo M, Peelen E, Pilutti LA.

Mult Scler Relat Disord. 2018 Nov;26:19-32. doi: 10.1016/j.msard.2018.08.022. Epub 2018 Aug 24. Review.

PMID:
30216755
5.

Exhaustive Multi-Parametric Assessment of the Behavioral Array of Daily Activities of Mice Using Cluster and Factor Analysis.

Yamamoto K, Gris KV, Sotelo Fonseca JE, Gharagozloo M, Mahmoud S, Simard C, Houle-Martel D, Cloutier T, Gris P, Gris D.

Front Behav Neurosci. 2018 Aug 30;12:187. doi: 10.3389/fnbeh.2018.00187. eCollection 2018.

6.

The Dual Immunoregulatory function of Nlrp12 in T Cell-Mediated Immune Response: Lessons from Experimental Autoimmune Encephalomyelitis.

Gharagozloo M, Mahmoud S, Simard C, Mahvelati TM, Amrani A, Gris D.

Cells. 2018 Aug 27;7(9). pii: E119. doi: 10.3390/cells7090119.

7.

Decline in peripheral blood NKG2D+CD3+CD56+ NKT cells in metastatic colorectal cancer patients.

Gharagozloo M, Rezaei A, Kalantari H, Bahador A, Hassannejad N, Maracy M, Nouri N, Sedghi M, Ghazanfari H, Bayat B.

Bratisl Lek Listy. 2018;119(1):6-11. doi: 10.4149/BLL_2018_002.

PMID:
29405723
8.

NLR-Dependent Regulation of Inflammation in Multiple Sclerosis.

Gharagozloo M, Gris KV, Mahvelati T, Amrani A, Lukens JR, Gris D.

Front Immunol. 2018 Jan 18;8:2012. doi: 10.3389/fimmu.2017.02012. eCollection 2017. Review. Erratum in: Front Immunol. 2018 Feb 28;9:404.

9.

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma.

Kouhpayeh S, Andalib A, Gharagozloo M, Sanei MH, Esmaeil N, Maracy MR.

Adv Biomed Res. 2017 Aug 28;6:108. doi: 10.4103/2277-9175.213668. eCollection 2017.

10.

Silymarin impacts on immune system as an immunomodulator: One key for many locks.

Esmaeil N, Anaraki SB, Gharagozloo M, Moayedi B.

Int Immunopharmacol. 2017 Sep;50:194-201. doi: 10.1016/j.intimp.2017.06.030. Epub 2017 Jun 30. Review.

PMID:
28672215
11.

Inhibition of Apoptosis and Proliferation in T Cells by Immunosuppressive Silymarine.

Almasi E, Gharagozloo M, Eskandari N, Almasi A, Sabzghabaee AM.

Iran J Allergy Asthma Immunol. 2017 Apr;16(2):107-119.

12.

Selective nuclear localization of siRNA by metallic versus semiconducting single wall carbon nanotubes in keratinocytes.

Huzil JT, Saliaj E, Ivanova MV, Gharagozloo M, Loureiro MJ, Lamprecht C, Korinek A, Chen DW, Foldvari M.

Future Sci OA. 2015 Nov 1;1(3):FSO17. doi: 10.4155/fso.15.15. eCollection 2015 Nov.

13.

Significant Contribution of Mouse Mast Cell Protease 4 in Early Phases of Experimental Autoimmune Encephalomyelitis.

Desbiens L, Lapointe C, Gharagozloo M, Mahmoud S, Pejler G, Gris D, D'Orléans-Juste P.

Mediators Inflamm. 2016;2016:9797021. doi: 10.1155/2016/9797021. Epub 2016 Aug 17.

14.

Modulation of Cytokine Production and Transcription Factors Activities in Human Jurkat T Cells by Thymol and Carvacrol.

Gholijani N, Gharagozloo M, Kalantar F, Ramezani A, Amirghofran Z.

Adv Pharm Bull. 2015 Dec;5(Suppl 1):653-60. doi: 10.15171/apb.2015.089. Epub 2015 Dec 31.

15.

Altered Th17/Treg Ratio in Recurrent Miscarriage after Treatment with Paternal Lymphocytes and Vitamin D3: a Double-Blind Placebo-Controlled Study.

Rafiee M, Gharagozloo M, Ghahiri A, Mehrabian F, Maracy MR, Kouhpayeh S, Pieper IL, Rezaei A.

Iran J Immunol. 2015 Dec;12(4):252-62. doi: IJIv12i4A3.

16.

The nod-like receptor, Nlrp12, plays an anti-inflammatory role in experimental autoimmune encephalomyelitis.

Gharagozloo M, Mahvelati TM, Imbeault E, Gris P, Zerif E, Bobbala D, Ilangumaran S, Amrani A, Gris D.

J Neuroinflammation. 2015 Oct 31;12:198. doi: 10.1186/s12974-015-0414-5.

17.

A flow cytometric approach to study the mechanism of gene delivery to cells by gemini-lipid nanoparticles: an implication for cell membrane nanoporation.

Gharagozloo M, Rafiee A, Chen DW, Foldvari M.

J Nanobiotechnology. 2015 Sep 29;13:62. doi: 10.1186/s12951-015-0125-1.

18.

The decrease in NKG2D+ Natural Killer cells in peripheral blood of patients with metastatic colorectal cancer.

Gharagozloo M, Kalantari H, Rezaei A, Maracy MR, Salehi M, Bahador A, Hassannejad N, Narimani M, Sanei MH, Bayat B, Ghazanfari H.

Bratisl Lek Listy. 2015;116(5):296-301.

PMID:
25924638
19.

Modulatory effects of thymol and carvacrol on inflammatory transcription factors in lipopolysaccharide-treated macrophages.

Gholijani N, Gharagozloo M, Farjadian S, Amirghofran Z.

J Immunotoxicol. 2016;13(2):157-64. doi: 10.3109/1547691X.2015.1029145. Epub 2015 Mar 27.

PMID:
25812626
20.

Effects of disulfiram on apoptosis in PANC-1 human pancreatic cancer cell line.

Dastjerdi MN, Babazadeh Z, Rabbani M, Gharagozloo M, Esmaeili A, Narimani M.

Res Pharm Sci. 2014 Jul-Aug;9(4):287-94.

21.

Therapeutic applications of nanomedicine in autoimmune diseases: from immunosuppression to tolerance induction.

Gharagozloo M, Majewski S, Foldvari M.

Nanomedicine. 2015 May;11(4):1003-18. doi: 10.1016/j.nano.2014.12.003. Epub 2015 Jan 14. Review.

PMID:
25596076
22.

Cadmium induces reactive oxygen species-dependent apoptosis in MCF-7 human breast cancer cell line.

Khojastehfar A, Aghaei M, Gharagozloo M, Panjehpour M.

Toxicol Mech Methods. 2015 Jan;25(1):48-55. doi: 10.3109/15376516.2014.985353.

PMID:
25403798
23.

Correlation of midkine serum level with pro- and anti-inflamatory cytokines in multiple sclerosis.

Shaygannejad V, Montazeri S, Jamshidian A, Tahani S, Gharagozloo M, Ashtari F, Vesal S, Hasheminia SJ, Dehghani L.

Iran J Immunol. 2014 Jun;11(2):134-8. doi: IJIv11i2A8.

24.

Serum levels of TGFβ, IL-10, IL-17, and IL-23 cytokines in β-thalassemia major patients: the impact of silymarin therapy.

Balouchi S, Gharagozloo M, Esmaeil N, Mirmoghtadaei M, Moayedi B.

Immunopharmacol Immunotoxicol. 2014 Aug;36(4):271-4. doi: 10.3109/08923973.2014.926916. Epub 2014 Jun 19.

PMID:
24945737
25.

Comparison of nucleostemin gene expression in CD133+ and CD133- cell population in colon cancer cell line HT29.

Zia-Jahromi N, Hejazi SH, Panjepour M, Parivar K, Gharagozloo M.

J Cancer Res Ther. 2014 Jan-Mar;10(1):68-72. doi: 10.4103/0973-1482.131375.

26.

Variations in T-helper 17 and Regulatory T Cells during The Menstrual Cycle in Peripheral Blood of Women with Recurrent Spontaneous Abortion.

Sereshki N, Gharagozloo M, Ostadi V, Ghahiri A, Roghaei MA, Mehrabian F, Andalib AA, Hassanzadeh A, Hosseini H, Rezaei A.

Int J Fertil Steril. 2014 Apr;8(1):59-66. Epub 2014 Mar 9.

27.

Dust events, pulmonary diseases and immune system.

Esmaeil N, Gharagozloo M, Rezaei A, Grunig G.

Am J Clin Exp Immunol. 2014 Feb 27;3(1):20-9. eCollection 2014. Review.

28.

Co-Administration of Silymarin and Deferoxamine against Kidney, Liver and Heart Iron Deposition in Male Iron Overload Rat Model.

Navidi-Shishaone M, Mohhebi S, Nematbakhsh M, Roozbehani S, Talebi A, Pezeshki Z, Eshraghi-Jazi F, Mazaheri S, Shirdavani S, Gharagozloo M, Moaeidi BA.

Int J Prev Med. 2014 Jan;5(1):110-6.

29.

Antibodies to interferon beta in patients with multiple sclerosis receiving CinnoVex, rebif, and betaferon.

Zare N, Zarkesh-Esfahani SH, Gharagozloo M, Shaygannejad V.

J Korean Med Sci. 2013 Dec;28(12):1801-6. doi: 10.3346/jkms.2013.28.12.1801. Epub 2013 Nov 26.

30.
31.

The apoptotic effects of sirtuin1 inhibitor on the MCF-7 and MRC-5 cell lines.

Dastjerdi MN, Salahshoor MR, Mardani M, Rabbani M, Hashemibeni B, Gharagozloo M, Kazemi M, Esmaeil N, Roshankhah Sh, Golmohammadi R, Mobarakian M.

Res Pharm Sci. 2013 Apr;8(2):79-89.

32.

Biased Treg/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms.

Jamshidian A, Shaygannejad V, Pourazar A, Zarkesh-Esfahani SH, Gharagozloo M.

J Neuroimmunol. 2013 Sep 15;262(1-2):106-12. doi: 10.1016/j.jneuroim.2013.06.007. Epub 2013 Jul 9.

PMID:
23845464
33.

Immunosuppressive effect of silymarin on mitogen-activated protein kinase signalling pathway: the impact on T cell proliferation and cytokine production.

Gharagozloo M, Jafari S, Esmaeil N, Javid EN, Bagherpour B, Rezaei A.

Basic Clin Pharmacol Toxicol. 2013 Sep;113(3):209-14. doi: 10.1111/bcpt.12088. Epub 2013 Jun 20.

34.

Protective Role of Silymarin and Deferoxamine Against Iron Dextran-induced Renal Iron Deposition in Male Rats.

Nematbakhsh M, Pezeshki Z, Moaeidi BA, Eshraghi-Jazi F, Talebi A, Nasri H, Baradaran S, Gharagozloo M, Safari T, Haghighi M.

Int J Prev Med. 2013 Mar;4(3):286-92.

35.

Immunomodulatory effects of silymarin in patients with β-thalassemia major.

Gharagozloo M, Karimi M, Amirghofran Z.

Int Immunopharmacol. 2013 Jun;16(2):243-7. doi: 10.1016/j.intimp.2013.04.016. Epub 2013 Apr 26.

PMID:
23624215
36.

Elevated serum levels of cell death circulating biomarkers, M30 and M65, in patients with β-thalassemia major.

Esmaeil N, Moayedi B, Gharagozloo M, Maracy MR.

Hemoglobin. 2013;37(4):404-10. doi: 10.3109/03630269.2013.790828. Epub 2013 Apr 19.

PMID:
23600495
37.

A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamine.

Moayedi B, Gharagozloo M, Esmaeil N, Maracy MR, Hoorfar H, Jalaeikar M.

Eur J Haematol. 2013 Mar;90(3):202-9. doi: 10.1111/ejh.12061. Epub 2013 Jan 20.

PMID:
23278124
38.

Cell cycle analysis of the CD133(+) and CD133(-) cells isolated from human colorectal cancer.

Gharagozloo M, Mirzaei HR, Bagherpour B, Rezaei A, Kalantari H, Sanei MH, Hosseini M, Mohajeri G, Tabatabai A, Hashemi M.

J Cancer Res Ther. 2012 Jul-Sep;8(3):399-403. doi: 10.4103/0973-1482.103520.

39.

Silymarin inhibits cell cycle progression and mTOR activity in activated human T cells: therapeutic implications for autoimmune diseases.

Gharagozloo M, Javid EN, Rezaei A, Mousavizadeh K.

Basic Clin Pharmacol Toxicol. 2013 Apr;112(4):251-6. doi: 10.1111/bcpt.12032. Epub 2012 Dec 24.

40.

Can plasma exchange therapy induce regulatory T lymphocytes in multiple sclerosis patients?

Jamshidian A, Gharagozloo M.

Clin Exp Immunol. 2012 Apr;168(1):75-7. doi: 10.1111/j.1365-2249.2011.04547.x.

41.
42.

The expression of Th1- and Th2-related chemokine receptors in women with recurrent miscarriage: the impact of lymphocyte immunotherapy.

Kheshtchin N, Gharagozloo M, Andalib A, Ghahiri A, Maracy MR, Rezaei A.

Am J Reprod Immunol. 2010 Aug 1;64(2):104-12. doi: 10.1111/j.1600-0897.2010.00829.x. Epub 2010 Mar 22.

PMID:
20331585
43.

Silymarin suppress CD4+ T cell activation and proliferation: effects on NF-kappaB activity and IL-2 production.

Gharagozloo M, Velardi E, Bruscoli S, Agostini M, Di Sante M, Donato V, Amirghofran Z, Riccardi C.

Pharmacol Res. 2010 May;61(5):405-9. doi: 10.1016/j.phrs.2009.12.017. Epub 2010 Jan 7.

PMID:
20056147
44.

Risk factors for latex sensitization in young children with myelomeningocele. Clinical article.

Majed M, Nejat F, Khashab ME, Tajik P, Gharagozloo M, Baghban M, Sajjadnia A.

J Neurosurg Pediatr. 2009 Sep;4(3):285-8. doi: 10.3171/2009.4.PEDS08364.

PMID:
19772416
45.

Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.

Gharagozloo M, Moayedi B, Zakerinia M, Hamidi M, Karimi M, Maracy M, Amirghofran Z.

Fundam Clin Pharmacol. 2009 Jun;23(3):359-65. doi: 10.1111/j.1472-8206.2009.00681.x. Epub 2009 May 7.

PMID:
19453758
46.
47.

Premature senescence of T lymphocytes from patients with beta-thalassemia major.

Gharagozloo M, Bagherpour B, Tahanian M, Oreizy F, Amirghofran Z, Sadeghi HM, Hourfar H, Moayedi B.

Immunol Lett. 2009 Jan 29;122(1):84-8. doi: 10.1016/j.imlet.2008.12.003. Epub 2008 Dec 30.

PMID:
19118576
48.

Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activity.

Gharagozloo M, Karimi M, Amirghofran Z.

Ann Hematol. 2009 Jan;88(1):21-7. doi: 10.1007/s00277-008-0564-y. Epub 2008 Aug 9.

PMID:
18690440
49.

Oestrogen promotes coronary angiogenesis even under normoxic conditions.

Nematbakhsh M, Ghadesi M, Hosseinbalam M, Khazaei M, Gharagozloo M, Dashti G, Rajabi P, Rafieian S.

Basic Clin Pharmacol Toxicol. 2008 Sep;103(3):273-7. doi: 10.1111/j.1742-7843.2008.00286.x. Epub 2008 Jul 18. Erratum in: Basic Clin Pharmacol Toxicol. 2009 May;104(5):417. Gharagozlo, Marjan [corrected to Gharagozloo, Marjan].

50.

The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: a comparison with desferrioxamine.

Gharagozloo M, Khoshdel Z, Amirghofran Z.

Eur J Pharmacol. 2008 Jul 28;589(1-3):1-7. doi: 10.1016/j.ejphar.2008.03.059. Epub 2008 Apr 6.

PMID:
18619590

Supplemental Content

Loading ...
Support Center